The overall goal of this project is to define the immunologic and virologic characteristics of the persistent cellular reservoirs for HIV-1, the extent of immune damage and potential for reconstitution, and the evolution of anti-HIV-1 T cell responses during the natural history of HIV-1 infection before and after therapeutic intervention. There are three specific aims: (1) The first is to determine the proportion and types of HIV-1 infected cells circulating in the blood stream responsible for maintaining the long-lived reservoir of viral infection; (2) The next is to determine the extent of lymphocyte regeneration by thymus-dependent and -independent pathways and the capacity for immune reconstitution in patients receiving PART, and lastly, (3) to characterize the cellular immune response in HIV-1 infected patients, the impact over time of chronic viral replication on the maintenance of these responses, and the impact of short- and long-term suppression of viral replication on the persistence of major histocompatibility complex (MHC)-class I-restricted CD8+ and MHC-class II-restricted CD4+ memory T cell responses. These studies will include determination of the viral variables associated with persistent cellular reservoirs following treatment of HIV-1 infection using new molecular techniques to detect and quantify viral transcripts and viral evolution in T cell subpopulations identified by fluorescence activated cell sorting (FACS). Studies will also include elucidating the mechanism and extent of T cell reconstitution using kinetic polymerase chain reaction (PCR)-based assays to quantify T cell excision circles and T cell V-beta genes in specific phenotypically defined T cell subsets. Additionally, the applicants will determine the dimensions of the virus-specific CD8+ T cell response in HIV-1- infected patients over time by flow cytometry using MHC class I/peptide tetramer staining, antigen-specific intracellular cytokine staining and classical T lymphocyte cytotoxicity assays. The investigators will measure virus-specific CD4+ T cell responses in patients over time using stimulation by recombinant HIV-1 p24 and gpl20 proteins and measurement of in vitro proliferation and intracellular cytokine staining detected by flow cytometry. From such data, detailed mathematical analyses can be done that provide not only a kinetic picture of viral pathogenesis, but also help establish theoretical principles to guide the rational approach to the development of efficacious treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI037613-07
Application #
6510588
Study Section
Special Emphasis Panel (ZAI1-ACS-A (J1))
Program Officer
Roe, Joanad'Arc C
Project Start
2000-04-15
Project End
2004-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
7
Fiscal Year
2002
Total Cost
$838,615
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Tipton, Laura; Cuenco, Karen T; Huang, Laurence et al. (2018) Measuring associations between the microbiota and repeated measures of continuous clinical variables using a lasso-penalized generalized linear mixed model. BioData Min 11:12
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Drozd, Daniel R; Kitahata, Mari M; Althoff, Keri N et al. (2017) Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr 75:568-576
Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390
Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N et al. (2017) HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76:319-329

Showing the most recent 10 out of 217 publications